Basic Information
Profusa's mission is to make the chemistry of our bodies easily accessible, thereby improving health and wellness. We are committed to becoming a leader in the development of real-time biosensors, providing unprecedented insights into our overall health status. Profusa's first clinical product, the Lumee Oxygen Platform™, is designed to report reliable tissue oxygen levels in various regions of interest, both acute and long-term. It can be used to monitor beneficial applications for damaged tissues, such as peripheral artery disease, which leads to vascular stenosis and reduced blood flow in the lower limbs; chronic wounds that do not heal properly (diabetic ulcers, pressure sores); and reconstructive surgery.
Profusa Inc.
California,United States of America
101~500 people
January 01, 2009
info@profusacorp.com

